Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
Reserves | 1,779.82 | 1,614.69 | 1,583.59 | 2,508.21 | 1,327.71 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1,949.23 | 1,784.10 | 1,753.00 | 2,677.62 | 1,497.12 |
Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Unsecured Loans | 9.95 | 18.67 | 15.54 | 20.08 | 34.63 |
Total Debt | 9.95 | 18.67 | 15.54 | 20.08 | 34.63 |
Other Liabilities | 248.40 | 246.30 | 254.22 | 263.00 | 260.29 |
Total Liabilities | 2,207.58 | 2,049.07 | 2,022.76 | 2,960.70 | 1,792.04 |
APPLICATION OF FUNDS : | |||||
Gross Block | 668.95 | 683.12 | 635.93 | 593.89 | 602.89 |
Less: Accumulated Depreciation | 385.31 | 361.86 | 305.99 | 263.26 | 216.00 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 283.64 | 321.26 | 329.94 | 330.63 | 386.89 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 14.32 | 13.93 | 20.31 | 30.50 | 13.21 |
Investments | 1,142.74 | 837.72 | 542.78 | 390.09 | 24.49 |
Current Assets, Loans & Advances | |||||
Inventories | 463.17 | 514.30 | 437.70 | 512.71 | 523.34 |
Sundry Debtors | 292.55 | 222.06 | 192.38 | 205.24 | 215.60 |
Cash and Bank Balance | 1,400.89 | 1,061.20 | 1,150.73 | 2,479.11 | 1,157.68 |
Loans and Advances | 108.70 | 155.08 | 167.62 | 108.05 | 274.71 |
Total Current Assets | 2,265.30 | 1,952.62 | 1,948.43 | 3,305.12 | 2,171.33 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 952.43 | 806.64 | 590.94 | 1,046.53 | 866.70 |
Provisions | 940.93 | 692.10 | 713.99 | 615.36 | 438.35 |
Total CL & Provisions | 1,893.35 | 1,498.74 | 1,304.94 | 1,661.90 | 1,305.05 |
Net Current Assets | 371.95 | 453.88 | 643.49 | 1,643.22 | 866.28 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 167.94 | 163.08 | 151.38 | 131.67 | 117.24 |
Deferred Tax Liability | 27.30 | 17.14 | 18.20 | 18.89 | 15.57 |
Net Deferred Tax | 140.64 | 145.94 | 133.18 | 112.78 | 101.67 |
Other Assets | 254.30 | 276.33 | 353.06 | 453.48 | 399.49 |
Total Assets | 2,207.58 | 2,049.05 | 2,022.76 | 2,960.70 | 1,792.03 |
Contingent Liabilities | 462.03 | 384.15 | 350.59 | 351.10 | 485.78 |